{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:09Z","timestamp":1790698809636,"version":"4.1.0"},"reference-count":193,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NIAMS","award":["K24AR064310"],"award-info":[{"award-number":["K24AR064310"]}]},{"name":"National Psoriasis Foundation, Aventis Pharmaceuticals, Ortho Pharmaceuticals, and Roche Dermatology"},{"name":"Dermatology Foundation, American Society for Dermatologic Surgery, and the American Acne Rosacea Society and Medicis"},{"name":"Acuderm, Advanced Tissue Sciences, Allergan, Aventis, Bristol-Myers Squibb, Combe, Curatek, Ferndale, Fujisawa, Hermal, Hoffman LaRoche, Galderma, Genderm, Glaxo Wellcome, Hill, Janssen, Mayrand, NeoStrata, Neutrogena, Novartis, Oclassen, Ortho, Person & Covey, Proctor & Gamble, RJR Nabisco, Schering-Plough, Shelton, SmithKline, Stiefel, 3M, United Catalyst, Upjohn, and Wolff Systems"},{"name":"Centocor (Janssen), Amgen, Abbott (Abbvie), Novartis, Celgene, Pfizer, and Lilly"},{"name":"numerous dermatology companies"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jaad.2013.08.042","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T10:41:07Z","timestamp":1381488067000},"page":"146-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Research gaps in psoriasis: Opportunities for future\u00a0studies"],"prefix":"10.1016","volume":"70","author":[{"given":"Caitriona","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Elmets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.M.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig L.","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reva","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Menter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.08.042_bib1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy","volume":"62","author":"Menter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care\u00a0for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions","volume":"65","author":"Menter","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics","volume":"58","author":"Gottlieb","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global Epidemiology of Psoriasis: A systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.08.042_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","article-title":"The natural history of psoriasis in 5,600 patients","volume":"148","author":"Farber","year":"1974","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2013.08.042_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.amepre.2013.01.004","article-title":"Psoriasis and psoriatic arthritis: a public health agenda","volume":"44","author":"Helmick","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib11","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/sj.jid.5700489","article-title":"Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes","volume":"126","author":"Christensen","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/jid.2010.350","article-title":"Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6","volume":"131","author":"Riveira-Munoz","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/jid.2009.319","article-title":"Molecular dissection of psoriasis: integrating genetics and biology","volume":"130","author":"Elder","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ng.313","article-title":"Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis","volume":"41","author":"de Cid","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.det.2003.12.001","article-title":"Psoriasis: future research needs and goals for the twenty-first century","volume":"22","author":"Griffiths","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2013.08.042_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2008.089367","article-title":"Familial aggregation of psoriatic arthritis","volume":"68","author":"Chandran","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrrheum.2011.169","article-title":"Genetics of susceptibility and treatment response in psoriatic arthritis","volume":"7","author":"O'Rielly","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.berh.2010.05.006","article-title":"Update on the genetics of spondyloarthritis\u2013ankylosing spondylitis and psoriatic arthritis","volume":"24","author":"Chandran","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib25","unstructured":"Przepiera-Bedzak H, Ciechanowicz A, Brzosko I, MB. Influence of VEGF gene polymorphisms on clinical features of psoriatic arthritis and SAPHO syndrome [abstract]. 3rd World Congress of Psoriasis and Psoriatic Arthritis. Stockholm, Sweden June 28-30, 2012."},{"key":"10.1016\/j.jaad.2013.08.042_bib26","unstructured":"Chandran V, Cook R, Thavaneswaran A, Lee K, Fawnda PDG. Time to event and progressive multi-state analyses confirm the association between human leukocyte antigen alleles and the development of arthritis mutilans in patients with psoriatic arthritis [abstract]. 3rd World Congress of Psoriasis and Psoriatic Arthritis. Stockholm, Sweden, June 28-30, 2012."},{"key":"10.1016\/j.jaad.2013.08.042_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib28","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A-Producing Cells and Are Found in Lesional Skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib29","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","article-title":"A subpopulation of CD163-positive macrophages is classically activated in psoriasis","volume":"130","author":"Fuentes-Duculan","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib30","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.08.042_bib31","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \"type 1,\" Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.08.042_bib32","first-page":"314","article-title":"The role of psychoneuroimmunology in the pathogenesis of psoriasis","volume":"46","author":"Farber","year":"1990","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2013.08.042_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddr331","article-title":"Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome","author":"Joyce","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jid.2011.348","article-title":"A subset of methylated CpG sites differentiate psoriatic from normal skin","volume":"132","author":"Roberson","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2013.08.042_bib36","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S0923-1811(00)00145-6","article-title":"The role of VEGF and thrombospondins in skin angiogenesis","volume":"24","author":"Detmar","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2013.08.042_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.2008.08889.x","article-title":"Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis","volume":"160","author":"Henno","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2353\/ajpath.2008.071074","article-title":"Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor","volume":"173","author":"Halin","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2013.08.042_bib39","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1111\/j.1365-2230.2008.02991.x","article-title":"Complete remission of psoriasis following bevacizumab therapy for colon cancer","volume":"34","author":"Akman","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib40","first-page":"479","article-title":"Neuropeptides and psoriasis","volume":"142","author":"Ryan","year":"2007","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1365-2133.2005.06817.x","article-title":"Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis","volume":"153","author":"Richards","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0190-9622(86)70034-0","article-title":"Stress, symmetry, and psoriasis: possible role of neuropeptides","volume":"14","author":"Farber","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib43","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1096\/fj.01-0254fje","article-title":"In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin","volume":"15","author":"Kono","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jaad.2013.08.042_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0625.2006.00382.x","article-title":"The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease","volume":"15","author":"O'Kane","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","article-title":"Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress","volume":"80","author":"Slominski","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaad.2013.08.042_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2133.2005.06330.x","article-title":"Unilateral remission of psoriasis following traumatic nerve palsy","volume":"152","author":"Joseph","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib47","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-4362.1990.tb03825.x","article-title":"The role of cutaneous sensory nerves in the maintenance of psoriasis","volume":"29","author":"Farber","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib48","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/jid.2011.60","article-title":"Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner","volume":"131","author":"Ostrowski","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1540-9740.2005.03716.x","article-title":"Smoking and psoriasis","volume":"4","author":"Behnam","year":"2005","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2013.08.042_bib50","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archderm.141.12.1580","article-title":"Relationship between smoking and the clinical severity of psoriasis","volume":"141","author":"Fortes","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.135.12.1490","article-title":"Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis","volume":"135","author":"Poikolainen","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2340\/00015555-0711","article-title":"Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis","volume":"89","author":"Wolk","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0625.2010.01224.x","article-title":"Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients","volume":"20","author":"Torii","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib54","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2011.10345.x","article-title":"Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress","volume":"164","author":"McAleer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaad.2013.08.042_bib56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2013.08.042_bib57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2230.2001.00831.x","article-title":"Psoriasis vulgaris\u2013a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis","volume":"26","author":"Prinz","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1568-9972(03)00059-4","article-title":"Disease mimicry\u2013a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry?","volume":"3","author":"Prinz","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2013.08.042_bib59","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2133.2009.09102.x","article-title":"Psoriasis and streptococci: the natural selection of psoriasis revisited","volume":"160","author":"McFadden","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib60","first-page":"241","article-title":"To treat or not to treat? Management of guttate psoriasis and pityriasis rosea in patients with evidence of group A Streptococcal infection","volume":"9","author":"Krishnamurthy","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00403-011-1189-x","article-title":"Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin","volume":"304","author":"Fahl\u00e9n","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2013.08.042_bib62","doi-asserted-by":"crossref","first-page":"e2719","DOI":"10.1371\/journal.pone.0002719","article-title":"Substantial alterations of the cutaneous bacterial biota in psoriatic lesions","volume":"3","author":"Gao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2013.08.042_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjd.12322","article-title":"Is chronic plaque psoriasis triggered by microbiota in the skin?","volume":"169","author":"Fry","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib64","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaad.2013.08.042_bib65","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib66","first-page":"54","article-title":"Coxsackie B viral infection in the etiology and clinical pathogenesis of psoriasis","author":"Korzhova","year":"2001","journal-title":"Lik Sprava"},{"key":"10.1016\/j.jaad.2013.08.042_bib67","doi-asserted-by":"crossref","first-page":"e1002514","DOI":"10.1371\/journal.pgen.1002514","article-title":"Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease","volume":"8","author":"Chen","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaad.2013.08.042_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2013.08.042_bib69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2013.1078","article-title":"Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study","volume":"149","author":"Paller","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2011.11.948","article-title":"Risks of developing psychiatric disorders in pediatric patients with psoriasis","volume":"67","author":"Kimball","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa066886","article-title":"Etanercept treatment for children and adolescents with plaque psoriasis","volume":"358","author":"Paller","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib73","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2010.04.004","article-title":"Long-term etanercept in pediatric patients with plaque psoriasis","volume":"63","author":"Paller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib74","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/01.inf.0000101846.83256.5a","article-title":"The march toward rational therapeutics in children","volume":"22","author":"Gorman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.08.042_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/0148581-200911010-00015","article-title":"The National Institutes of Health and the Best Pharmaceuticals for Children Act","volume":"11","author":"Zajicek","year":"2009","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaad.2013.08.042_bib76","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2013.08.042_bib77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and post partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib78","first-page":"183","article-title":"Pregnancy outcome in women with psoriasis","volume":"53","author":"Ben-David","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib80","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jaad.2009.05.004","article-title":"Pregnancy outcomes in psoriasis: why do we know so little?","volume":"61","author":"Horn","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2008.03.018","article-title":"Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases","volume":"59","author":"Lam","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib82","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","author":"Chi","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2013.08.042_bib83","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2133.2011.10513.x","article-title":"Evidence-based (S3) guideline on topical corticosteroids in pregnancy","volume":"165","author":"Chi","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib84","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/jid.2010.392","article-title":"Safety of topical corticosteroids in pregnancy: a population-based cohort study","volume":"131","author":"Chi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib85","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.a.20130","article-title":"Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy","volume":"120A","author":"Edwards","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2013.08.042_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/0891693031000067296","article-title":"Immunosuppressive drug use in pregnancy","volume":"36","author":"Petri","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2013.08.042_bib87","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/S0041-1345(97)00458-2","article-title":"Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun","volume":"29","author":"Lamarque","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2013.08.042_bib88","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2013.08.042_bib89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database","volume":"36","author":"Carter","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib90","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis","volume":"99","author":"Katz","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.08.042_bib91","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3899\/jrheum.090141","article-title":"Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?","volume":"36","author":"Winger","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib92","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaad.2013.08.042_bib93","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105924","article-title":"Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum","volume":"68","author":"Murashima","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib94","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/keq185","article-title":"Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding","volume":"49","author":"Berthelsen","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2013.08.042_bib95","unstructured":"Stelara Prescribing Information. Available at: http:\/\/www.stelarainfo.com\/pdf\/PrescribingInformation.pdf.%C2%A0Last. Accessed June 21, 2012."},{"key":"10.1016\/j.jaad.2013.08.042_bib96","first-page":"1240","article-title":"Treatment of severe psoriasis with ustekinumab during pregnancy","volume":"11","author":"Andrulonis","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib97","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199801270-00019","article-title":"Breast-feeding during treatment with cyclosporine","volume":"65","author":"Nyberg","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2013.08.042_bib98","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00054725-200608000-00020","article-title":"Successful use of adalimumab (Humira) for Crohn's disease in pregnancy","volume":"12","author":"Mishkin","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib99","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.0022-202X.2004.23448.x","article-title":"A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis","volume":"123","author":"Kauffman","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2012.10.063","article-title":"Geriatric dermatology: Part I. Geriatric pharmacology for the dermatologist","volume":"68","author":"Endo","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib102","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaad.2010.05.014","article-title":"Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation","volume":"65","author":"Grozdev","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ncprheum0987","article-title":"New insights into the pathogenesis and genetics of psoriatic arthritis","volume":"5","author":"Nograles","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2013.08.042_bib104","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib105","article-title":"Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)","author":"Theander","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib106","unstructured":"Kirkham B, Li W, Boggs R, Nab H, Tarallo M. Early treatment of psoriatic arthritis is associated with improved outcomes: findings from the etanercept PRESTA trial [abstract]. 3rd World Congress of Psoriasis and Psoriatic Arthritis. Stockholm, Sweden, June 28-30, 2012."},{"key":"10.1016\/j.jaad.2013.08.042_bib107","doi-asserted-by":"crossref","first-page":"176298","DOI":"10.1155\/2012\/176298","article-title":"Psoriatic arthritis: an update","volume":"2012","author":"Lloyd","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.jaad.2013.08.042_bib108","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","article-title":"High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires","volume":"72","author":"Haroon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib109","unstructured":"Korotaeva T, Krasnenko S, Loginova E, Goryachev D, Smirnov A. Clinical examination versus magnetic resonance imaging of the hand and foot: its usefulness in early detection of psoriatic arthritis among patients with psoriasis [abstract]. 3rd World Congress of Psoriasis and Psoriatic Arthritis. Stockholm, Sweden, June 28-30, 2012."},{"key":"10.1016\/j.jaad.2013.08.042_bib110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib111","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-3083.2010.03656.x","article-title":"Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community","volume":"24","author":"Menter","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2230.2010.03877.x","article-title":"Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study","volume":"36","author":"Tobin","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib113","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib114","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jid.2009.321","article-title":"Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort","volume":"130","author":"Wakkee","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib115","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/jid.2010.399","article-title":"Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk","volume":"131","author":"Stern","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib116","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/jid.2011.32","article-title":"Psoriasis and cardiovascular risk: strength in numbers, part II","volume":"131","author":"Gelfand","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib117","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib118","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","article-title":"Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II","volume":"167","author":"Setty","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib119","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archdermatol.2009.48","article-title":"Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses","volume":"145","author":"Qureshi","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib122","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archdermatol.2012.1401","article-title":"Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis","volume":"148","author":"Azfar","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib123","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2013.08.042_bib124","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib126","first-page":"179","article-title":"Psoriasis and cardiovascular disorders","volume":"147","author":"Ryan","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib127","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0029-1222610","article-title":"Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors","volume":"35","author":"Gisondi","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jaad.2013.08.042_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","article-title":"Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis","volume":"63","author":"Armstrong","year":"2011","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2013.08.042_bib129","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjcard.2008.10.004","article-title":"AJC editor's consensus: psoriasis and coronary artery disease","volume":"102","author":"Friedewald","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaad.2013.08.042_bib130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib131","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1468-3083.2010.03947.x","article-title":"Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study","volume":"25","author":"Boehncke","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib132","first-page":"1","article-title":"Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib133","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00403-010-1108-6","article-title":"Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial","volume":"303","author":"Boehncke","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2013.08.042_bib134","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2133.2008.08628.x","article-title":"Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis","volume":"159","author":"Strober","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib135","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.08.042_bib136","first-page":"864","article-title":"Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials","volume":"306","author":"Ryan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.08.042_bib137","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1468-3083.2012.04500.x","article-title":"Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12\/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials","volume":"27","author":"Tzellos","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib138","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2013.01.011","article-title":"Major cardiovascular events associated with anti-IL 12\/23 agents: A tale of two meta-analyses","volume":"68","author":"Dommasch","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/sim.4780090307","article-title":"Bias in the one-step method for pooling study results","volume":"9","author":"Greenland","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib140","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjd.12214","article-title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","volume":"168","author":"Papp","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib141","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1381\/0960892041975569","article-title":"Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity","volume":"14","author":"Higa-Sansone","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.jaad.2013.08.042_bib142","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2133.2005.06781.x","article-title":"Diet and psoriasis: experimental data and clinical evidence","volume":"153","author":"Wolters","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib143","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial","volume":"88","author":"Gisondi","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jaad.2013.08.042_bib144","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib145","first-page":"280","article-title":"The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey","volume":"137","author":"Krueger","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib146","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000093848","article-title":"Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis","volume":"213","author":"Schmitt","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.08.042_bib147","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000102029","article-title":"Role of depression in quality of life for patients with psoriasis","volume":"215","author":"Schmitt","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.08.042_bib148","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.genhosppsych.2006.12.004","article-title":"Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach","volume":"29","author":"Schmitt","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jaad.2013.08.042_bib149","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.08.042_bib150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00006842-199809000-00020","article-title":"Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA)","volume":"60","author":"Kabat-Zinn","year":"1998","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib151","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2133.2002.04622.x","article-title":"A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy","volume":"146","author":"Fortune","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib152","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/000155599750009870","article-title":"Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients","volume":"79","author":"Schmid-Ott","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib153","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/LGT.0b013e31824b9e5e","article-title":"Vulvar psoriasis in adults and children: a clinical audit of 194 cases and review of the literature","volume":"16","author":"Kapila","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib154","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archdermatol.2012.370","article-title":"Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting","volume":"148","author":"Gelfand","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib155","first-page":"546","article-title":"Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis","volume":"41","author":"Miller","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib156","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib157","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archderm.1958.01560080060010","article-title":"Treatment of psoriasis with folic acid antagonists","volume":"78","author":"Edmundson","year":"1958","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.jaad.2013.08.042_bib158","first-page":"116","article-title":"Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial","volume":"158","author":"Flytstr\u00f6m","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib159","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib160","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2010.10.041","article-title":"Methotrexate and psoriasis: consensus conference","volume":"64","author":"Kalb","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2013.08.042_bib161","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","article-title":"Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity","volume":"25","author":"Montaudi\u00e9","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.08.042_bib162","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib163","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/rheumatology\/kes001","article-title":"A randomized placebo-controlled trial of methotrexate in psoriatic arthritis","volume":"51","author":"Kingsley","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2013.08.042_bib164","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/ard.2011.152223","article-title":"Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study","volume":"71","author":"Baranauskaite","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib165","first-page":"381","article-title":"Psoriasis\u2013chemotherapy with aminopterin and methotrexate","volume":"1","author":"Rees","year":"1962","journal-title":"Skin (Los Angeles)"},{"key":"10.1016\/j.jaad.2013.08.042_bib166","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.1964.01600060010002","article-title":"Aminopterin for psoriasis. A decade's observation","volume":"90","author":"Rees","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib167","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00280-005-0115-3","article-title":"Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy","volume":"57","author":"Cole","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaad.2013.08.042_bib168","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-007-0576-7","article-title":"Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia","volume":"62","author":"Cole","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaad.2013.08.042_bib169","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.112.195479","article-title":"Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter","volume":"342","author":"Menter","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2013.08.042_bib170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1056\/NEJMp0905631","article-title":"Comparative-effectiveness research\u2013implications of the Federal Coordinating Council's report","volume":"361","author":"Conway","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib171","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.08.042_bib172","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/13543784.2012.669372","article-title":"Current investigational drugs in psoriasis","volume":"21","author":"Ryan","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2013.08.042_bib173","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpba.2013.01.031","article-title":"Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay","volume":"78-79","author":"Wang","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jaad.2013.08.042_bib174","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bjd.12341","article-title":"Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study","volume":"169","author":"Mahil","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib175","doi-asserted-by":"crossref","unstructured":"Garc\u00eas S, Demengeot J, Benito-Garcia E. The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis. Ann Rheum Dis doi:10.1136\/annrheumdis-2012-202220. Published online December 6, 2012.","DOI":"10.1136\/annrheumdis-2012-202220"},{"key":"10.1016\/j.jaad.2013.08.042_bib176","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03256357","article-title":"The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis","volume":"14","author":"Ryan","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jaad.2013.08.042_bib177","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/jid.2008.16","article-title":"Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis","volume":"128","author":"Warren","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib178","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib179","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/jid.2011.376","article-title":"TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis","volume":"132","author":"Tejasvi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib180","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.4049\/jimmunol.178.11.7442","article-title":"Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients","volume":"178","author":"Haider","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.08.042_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-10-1","article-title":"Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept","volume":"10","author":"Su\u00e1rez-Fari\u00f1as","year":"2010","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib182","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/annrheumdis-2012-202545","article-title":"Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective","volume":"72","author":"Vincent","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.08.042_bib183","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2010.09.734","article-title":"The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Dommasch","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib184","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000156599","article-title":"Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project","volume":"217","author":"Naldi","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.08.042_bib185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archdermatol.2009.319","article-title":"Recent trends in systemic psoriasis treatment costs","volume":"146","author":"Beyer","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib186","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14656566.7.2.157","article-title":"Cost-effectiveness of moderate-to-severe psoriasis treatment","volume":"7","author":"Miller","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2013.08.042_bib187","doi-asserted-by":"crossref","first-page":"477","DOI":"10.12968\/bjon.2010.19.8.47632","article-title":"Biological nurse specialist: goodwill to good practice","volume":"19","author":"Palmer","year":"2010","journal-title":"Br J Nurs"},{"key":"10.1016\/j.jaad.2013.08.042_bib188","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2133.2008.08987.x","article-title":"Care of patients with psoriasis: an audit of U.K. services in secondary care","volume":"160","author":"Eedy","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib189","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2133.2002.04901.x","article-title":"A randomized controlled trial of nurse follow-up clinics: do they help patients and do they free up consultants' time?","volume":"147","author":"Gradwell","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib190","first-page":"38","article-title":"The benefits of switching to nurse-led management of patients with psoriasis","volume":"20","author":"Riddoch","year":"2005","journal-title":"Prof Nurse"},{"key":"10.1016\/j.jaad.2013.08.042_bib191","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archdermatol.2009.375","article-title":"Pilot study using teledermatology to manage high-need patients with psoriasis","volume":"146","author":"Fr\u00fchauf","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib192","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1440-0960.2011.00852.x","article-title":"Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients with psoriasis","volume":"53","author":"Fr\u00fchauf","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2013.08.042_bib193","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2340\/00015555-1148","article-title":"Teledermatological monitoring of psoriasis patients on biologic therapy","volume":"91","author":"Koller","year":"2011","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:28:26Z","timestamp":1759271306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213009195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":193,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0190962213009195"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.08.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research gaps in psoriasis: Opportunities for future\u00a0studies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}